lobbying_activities: 2273704

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2273704	2b3d4e94-c746-41f2-aff4-019be19c8c60	Q1	ROCK & ASSOCIATES	33545	WELLNESS PHARMACY	2019	first_quarter	PHA	H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	11250		0	0	2019-04-18T15:55:54.950000-04:00